If you've ever felt like stress makes your PMDD symptoms worse, emerging research supports that connection. This review brings together evidence from multiple studies to explore how stress and inflammation in the brain may be key drivers behind PMS and PMDD symptoms.
The authors explain that women with PMS and PMDD tend to perceive stress more intensely during the premenstrual phase. In fact, across 48 studies reviewed in earlier research, 92% confirmed that stress plays a role in developing or worsening these conditions. The review also highlights that people with PMDD may have a harder time using healthy coping strategies for stress, which can create a cycle of worsening symptoms.
A central idea in the review is that stress triggers inflammation throughout the body, and this inflammation can eventually reach the brain. Once in the brain, inflammation may disrupt several systems that are important for mood regulation — including serotonin (a brain chemical targeted by SSRIs, which are effective PMDD treatments), GABA (a calming brain chemical), BDNF (a protein that supports healthy brain function), and the hormonal systems that control both the menstrual cycle and the body's stress response. The natural drop in estrogen and progesterone before your period may remove some of the brain's protection against inflammation, making this phase especially vulnerable.
While this review pulls together a compelling picture of how stress and brain inflammation might contribute to PMDD, the authors note that much of this research is still in early stages. Many of the specific connections are based on studies of depression or animal models rather than PMDD directly. Still, this framework opens up promising directions for future treatments that might target inflammation alongside traditional approaches.
Key findings
- Women with PMS/PMDD perceive stressors more intensely during the premenstrual phase compared to controls, with 92% of 48 reviewed studies confirming the role of stress in PMS/PMDD development
- Clinical evidence shows women with PMS have significantly higher levels of IL-4, IL-10, IL-12, and IFN-γ compared to healthy controls, and elevated C-reactive protein levels positively correlate with PMDD symptom severity
- In PMDD, cortical GABA levels increase from the follicular to luteal phase (opposite to the decrease seen in healthy women), while plasma GABA levels are lower throughout the menstrual cycle in women with premenstrual irritability and severe depression
- BDNF levels in PMDD patients are significantly higher during the luteal phase than the follicular phase, and this increase is strongly correlated with depressive symptoms, potentially reflecting a compensatory response to chronic stress and inflammation
- Women with PMS exhibit blunted cortisol responses to the Trier Social Stress Test compared to controls, and women with severe PMDD show markedly reduced heart rate variability across all menstrual cycle phases
- Animal model studies found elevated expression of TLR-4, NF-κB p65, TNF-α, IL-6, and IL-1β in the basolateral amygdala in a PMDD model compared to controls, which were reduced by fluoxetine intervention
Methods, briefly
Narrative review synthesizing clinical and preclinical evidence on the relationships between neuroinflammation, stress, and PMS/PMDD. Draws on human clinical studies (cross-sectional, longitudinal, neuroimaging), animal models (rodent PMDD models using ovariectomy and hormone induction), and molecular/cellular studies. No systematic search protocol or meta-analytic methods described.
Limitations to keep in mind
- Narrative review without systematic search methodology, increasing risk of selection bias in cited evidence
- Much of the inflammation and neurotransmitter evidence comes from studies on depression, anxiety, or other conditions rather than PMS/PMDD specifically
- Animal model studies referenced used both male and female rodents or only male animals, limiting direct applicability to PMS/PMDD
- Direct clinical evidence linking neuroinflammation causally to PMS/PMDD remains limited; many connections are hypothesized rather than empirically established
- Some authors were employed by a pharmaceutical company, representing a potential conflict of interest
The latest PMDD research, in your pocket
The app’s research feed is updated daily with newly published, peer-reviewed PMDD work - summarized in plain language.